Results 131 to 140 of about 13,781 (198)

Reversible Rituximab-Induced Bronchiectasis: A Pediatric Case Report and Literature Review. [PDF]

Am J Case Rep
AlHarbi N, AlEidan A, AlZanbagi MA.
europepmc   +1 more source

The Art of Sequencing Disease-Modifying Therapies in Multiple Sclerosis. [PDF]

Neurol Neuroimmunol Neuroinflamm
Dersch RS, Pfeuffer S, Bsteh G, Wiendl H.   +3 more
europepmc   +1 more source

Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome. [PDF]

Kidney Int Rep
Chan EY, Au CT, Yu EL, Angeletti A, Arslan Z, Boyer O, Chan CY, Colucci M, Dorval G, Dossier C, Ghiggeri GM, Hamada R, Hogan J, Ishikura K, Kamei K, Kemper MJ, Ma AL, Parekh RS, Radhakrishnan S, Robinson C, Shen Q, Sinha R, Subun C, Teo S, Vivarelli M, Webb H, Xu H, Yamamura T, Yap HK, Tullus K.   +29 more
europepmc   +1 more source

Good's syndrome and infections in a large retrospective cohort of thymoma. [PDF]

Front Immunol
Jia W, Jin L, Huan X, Yan C, Xi J, Pang L, Zhao C, Song J, Chu X, Luo S.   +9 more
europepmc   +1 more source

Severe Hypogammaglobulinemia (IgG) During Efgartigimod Therapy in Neurological Practice: A Real-World Case Series. [PDF]

Cureus
Espinosa PS, Preisler J, Motiño Villanueva A, Bellon MB, Hennekens CH.   +4 more
europepmc   +1 more source

Implementing calculated globulin screening for immunodeficiencies: The benefits and challenges. [PDF]

J Hum Immun
Jolles S, Poli C, Rider NL, Negritu G, Rendschmidt T, Condino-Neto A.   +5 more
europepmc   +1 more source

Cytomegalovirus reactivation in patients with multiple myeloma receiving bispecific antibodies. [PDF]

Blood Adv
Sastre-Escolà E, Reynolds GK, Yong MK, Zhu V, Harrison SJ, Khot AS, Slavin MA, Teh BW.   +7 more
europepmc   +1 more source

Optimizing the Use of Serum Immunofixation for the Detection of Monoclonal Components in Hypogammaglobulinemia: Insights From a Tertiary-Care Biochemistry Laboratory. [PDF]

Cureus
Krimi K, El Moujtahide D, Sebbar EH, Choukri M.   +3 more
europepmc   +1 more source

Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma. [PDF]

Ann Hematol
Perrone S, Tomasello R, Raso S, Annibali O, Tafuri M, Mattana M, Soriano T, Fanciullo D, Assanto GM, Pedone GL, Baldacci E, Santacroce E, Markovic U, Giuffrida G, Ingrascì MG, Biglietto M, Cammarata C, Totaro M, Ligia S, Fattizzo B, Santoro C, Siragusa S, Napolitano M.   +22 more
europepmc   +1 more source

The Immunologic Paradox of BTK Inhibitors in Chronic Lymphocytic Leukemia: Selectivity, Hypogammaglobulinemia, and Infection Risk. [PDF]

Cancers (Basel)
Andreescu M, Tudorache SI, Moldovan CA, Moldovan AD, Cochior D, Popov V, Andreescu B, Ionescu D, Padurariu-Covit MD.   +8 more
europepmc   +1 more source